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A Noble Target Molecule of Nobiletin is Crucial for Cardiac Hypertrophic
Responses
YOICHI SUNAGAWA1,2, MASAFUMI FUNAMOTO1, MASATOSHI FUJITA3,
KOJI HASEGAWA2, TATSUYA MORIMOTO1
1Division of Molecular Medicine, School of Pharmaceutical Sciences, University of
Shizuoka, Shizuoka, Japan, 2Division of Translational Research, Clinical Research
Institute, Kyoto Medical Center, National Hospital Organization, Kyoto, Japan,
3Social Welfare Corporation Uji Hospital, Kyoto, Japan
Introduction: Maladaptive hypertrophy is being recognized as a critical event dur-
ing the development of heart failure. We found that nobiletin, a poly-methoxy flavo-
noids derived from Citrus unshu, repressed hypertrophic responses in
cardiomyocytes and prevented the development of heart failure after myocardial
infarction in rats.
Thus, nobiletin is expected as a useful agent for heart failure. However, the target
molecule of nobiletin in cardiomyocytes is still unclear. Methods and Results:
First, we investigated the localization of nobiletin within cardiomyocytes by gener-
ating nobiletin conjugated with Tokyo-green, a fluorescein analogue (TG-nobiletin).
We confirmed that TG-nobiletin retains its ability to inhibit cardiomyocyte hyper-
trophy in a manner similar with natural nobiletin, and found TG-nobiletin was
distributed in a cytoplasm of cardiomyocytes. Next, to identify nobiletin-binding
proteins (NBPs), we synthesized biotin-conjugated nobiletin (Bio-nobiletin). Pro-
tein extracts form rat hearts were incubated with Bio-nobiletin or Biotin alone
and binding proteins were precipitated with streptavidin beads. By mass-spectro-
metric analysis, we identified 162 novel NBPs in the heart. In addition, Bio-
nobiletin pull-down assay showed that Bio-nobiletin could interact with recombi-
nant NBP1, which related to metabolic processes. In cultured cardiomyocytes,
knockdown of NBP1 lost the inhibitory effects of nobiletin against phenyleph-
rine-induced cardiomyocyte hypertrophy. Conversely, overexpression of NBP1 in-
hibited phenylephrine-induced hypertrophy. Conclusions: These results suggest
that NBP1 may be a novel molecular target of nolitetin, a potent therapeutic agent
for cardiac hypertrophy.O-007
Mitochondrial Function as a Potential Mediator of Substrate Switching in the
Heart
TAKAO KATO1, TETSUO SHIOI2, AKIRA KAWAMOTO2, TAKESHI KIMURA2
1Cardiovascular Center, the Tazuke Kofukai Medical Research Institute, Kitano
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Kyoto University
Purpose: We previously reported that glucose uptake increased markedly and fatty
acid uptake decreased at the congestive heart failure (CHF) stage, associated with
decreased gene expression related to mitochondrial function in a rat model of heart
failure. The purpose of the study was to clarify the link between the changes of sub-
strate utilization and mitochondrial function. Methods and Results: Carbonyl cya-
nide m-chlorophenylhydrazone (CCCP), a compound known to reduce the
mitochondrial membrane potential, was injected intraperitoneally into Sprague-
Dawley rats. The rats administered CCCP showed a transiently decreased systolic
function on echocardiography and a decrease in cardiac phosphocreatine and ATP
compared to the vehicle group on in vivo 31P magnetic resonance spectroscopy.
Since ATP was mainly produced by mitochondrial membrane potentials, decreased
ATP caused by CCCP injection means dispersion of the mitochondrial function. In
ex vivo perfused hearts, CCCP also decreased the mitochondrial membrane potential
assessed by two-photon laser microscopy. The glucose uptake increased 1.96 fold
compared to the vehicle group and the fatty acid uptake decreased 0.48 fold 90 mi-
nutes after CCCP administration, indicating that mitochondrial dysfunction caused
the changes in substrate uptake. Conclusions: This rat model using CCCP could
be used as a model of mitochondrial dysfunction. Mitochondrial dysfunction may
be closely associated with metabolic substrat switching in the heart, especially in
the failing heart.O-008
Impaired Mitochondrial Oxidative Phosphorylation and Fatty Acid Oxidation
with Enhanced Mitochondrial Oxidative Stress in Spontaneously-occurring
Feline Hypertrophic Cardiomyopathy
TAKASHI YOKOTA1, LISELOTTE B. CHRISTIANSEN2, FLEMMING DELA2
1Department of Cardiovascular Medicine, Hokkaido University Graduate School of
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Mitochondria play a crucial role in the development of various cardiovascular dis-
eases. The aim of the study was to elucidate the role of mitochondrial dysfunction
and oxidative stress in hypertrophic cardiomyopathy (HCM).The cardiac and skeletal muscle were obtained from 9 spontaneously-occurring do-
mestic HCM cats with preserved systolic function and 13 age-matched control cats.
The capacities of mitochondrial oxidative phosphorylation (OXPHOS) and fatty acid
oxidation were assessed with permeabilized muscle fibers and isolated mitochondria
by using high-resolution respirometry. Reactive oxygen species (ROS) generation
originated from isolated mitochondria was assessed by using spectrofluorometer. Thi-
obarbituric reactive substances (TBARS), lipid peroxides, were also measured as an
oxidative stress marker. Mitochondrial state 3 respiration with complex I-linked sub-
strates and fatty acid oxidation in the heart were significantly depressed in HCM cats.
Furthermore, mitochondrial ROS generation during state 3 with complex I-linked
substrates and TBARS in the heart were significantly greater in HCM cats. In
contrast, there were no significant differences in mitochondrial function and oxidative
stress in the skeletal muscle. Mitochondrial OXPHOS capacity with complex I-linked
substrates and fatty acid oxidation were impaired with enhanced mitochondrial
oxidative stress in feline HCM heart. These findings provide new insight into patho-
physiology of HCM and support the hypothesis that to restore normal redox-state is
beneficial in the treatment of HCM.O-009
Mst1 Plays a Cell-protective Role in the Heart Through FoxO1 and C/EBP-b
Phosphorylation
YASUHIRO MAEJIMA1, JUNICHI SADOSHIMA2, MITSUAKI ISOBE1
1Department of Cardiovascular Medicine, Tokyo Medical and Dental University,
2Department of Cell Biology and Molecular Medicine, Rutgers New Jersey
Medical School
Mst1 kinase promotes apoptosis, thereby playing a crucial role in mediating cardiac
dysfunction in response to stress. Mst1 also stimulates a cell-protective mechanism
through FoxO1 as negative feedback to counteract its strong pro-apoptotic actions. In
order to clarify how Mst1 mediates this cell-protective mechanism in the heart, Tg-
DN-Mst1 were subjected to 2-h of prolonged ischemia. Tg-DN-Mst1 hearts exhibited
a significantly greater infarcted area than wild-type hearts, suggesting that the cardio-
protective effect of Mst1 dominates the pro-apoptotic effect. FoxO1 upregulated anti-
oxidant genes, including catalase, and inhibited pro-apoptotic genes, including FasL, in
cardiomyocytes, and these effects upon gene expression were attenuated when endog-
enous Mst1 was inhibited. Chromatin immunoprecipitation assays revealed that Mst1
inhibits binding of FoxO1 to the FasL promoter, but promotes binding of FoxO1 to
the catalase promoter. Reporter gene assays indicated that theC/EBP-b binding element
in the catalase promoter, but not the FoxO1 binding element, is critical for Mst1-medi-
ated catalase gene upregulation. Interaction between FoxO1 and C/EBP-b was
enhanced in the presence ofMst1.Mass spectrometry showed thatMst1 phosphorylates
C/EBP-b at Thr299. Phosphorylation of C/EBP-b byMst1 promoted binding of C/EBP-
b to DNA. Knockdown of C/EBP-b reversed the protective effects of FoxO1 against
Mst1-induced apoptosis. In summary, Mst1-mediated phosphorylation of both
FoxO1 and C/EBP-b stimulates a cell-protective mechanism by facilitating FoxO1-
C/EBP-b interaction and C/EBP-b-mediated transcription in the heart.
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Wnt/b-catenin Signaling Promotes Heart Failure-Induced Skeletal Myopathy
through Direct Interaction with FoxO
KATSUKI OKADA1, ATSUHIKO NAITO1,2, ICHIRO SHIOJIMA3, YASUSHI
SAKATA1, ISSEI KOMURO2
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Heart failure-induced skeletal myopathy is a major cause of exercise intolerance in
the patients of chronic heart failure (CHF). During skeletal myopathy, muscle fiber
type shifts from type I fatigue resistant fiber toward type IIb fatigable fiber. Forkhead
box O (FoxO) transcription factors have been reported to mediate skeletal myopathy
in CHF. We recently reported that serum from CHF model mice activated Wnt/b-cat-
enin signaling more potently than serum from normal mice. Recent studies have re-
vealed that b-catenin activates FoxO signaling as well as TCF-mediated canonical
Wnt signaling. Here, we investigated the molecular mechanism of skeletal myopathy
during CHF. We used dilated cardiomyopathy (DCM) model mice caused by troponin
mutation as CHF model.
Immunofluorescent staining revealed that type IIb fatigable fiber was increased in
skeletal muscle of DCM mice.
Expression of both TCF and FoxO target gene was increased in the skeletal muscle
of DCM model mice, which was associated with nuclear accumulation of b-catenin
and FoxO1 protein. Both recombinant Wnt3a and the serum from DCM model mice
promoted FoxO1 nuclear translocation, increased FoxO target gene expression, and
altered the muscle fiber type toward type IIb fiber in C2C12 myotubes. These results
suggest that increased serum Wnt activity in CHF promotes skeletal myopathy
through direct interaction with FoxO signaling. Our findings may provide new ther-
apeutic targets of skeletal myopathy in CHF.
